Cargando…

COL19A1 is a predictive biomarker for the responsiveness of esophageal squamous cell carcinoma patients to immune checkpoint therapy

BACKGROUND: The use of neoadjuvant immunotherapy plus chemotherapy has revolutionized the management of esophageal squamous cell carcinoma (ESCC) patients. Nevertheless, patients who would maximally benefit from these therapies have not been identified. METHODS: We collected postoperative specimens...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Jian‐Hua, Lin, Ju‐Ze, Qiu, Qianhui, Zhu, Changbin, Li, Weiwei, Li, Qian, Huang, Zhan, Xia, Xueer, Qiao, Guibin, Tang, Jiming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons Australia, Ltd 2023
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10175035/ https://www.ncbi.nlm.nih.gov/pubmed/37005910 http://dx.doi.org/10.1111/1759-7714.14873

Ejemplares similares

A case report of immune checkpoint inhibitor nivolumab combined with anti-angiogenesis agent anlotinib for advanced esophageal squamous cell carcinoma
por: Tang, Yong, et al.
Publicado: (2019)

Optimal Range of Lymphadenectomy in Pathological Stage T1 and T2 Esophageal Squamous Cell Carcinoma
por: Wu, Hansheng, et al.
Publicado: (2021)

Orchestration of immune checkpoints in tumor immune contexture and their prognostic significance in esophageal squamous cell carcinoma
por: Zhao, Jing-Jing, et al.
Publicado: (2018)

Predictions for high COL1A1 and COL10A1 expression resulting in a poor prognosis in esophageal squamous cell carcinoma by bioinformatics analyses
por: Li, Yang, et al.
Publicado: (2020)

A novel prognostic model: which group of esophageal squamous cell carcinoma patients could benefit from adjuvant chemotherapy
por: Zhou, Zihao, et al.
Publicado: (2022)

METTL3 Facilitates Tumor Progression by COL12A1/MAPK Signaling Pathway in Esophageal Squamous Cell Carcinoma
por: Li, Jiali, et al.
Publicado: (2022)

Serum Metabolomics for Biomarker Screening of Esophageal Squamous Cell Carcinoma and Esophageal Squamous Dysplasia Using Gas Chromatography-Mass Spectrometry
por: Zhang, Su, et al.
Publicado: (2020)

Salivary microbiota may predict the presence of esophageal squamous cell carcinoma
por: Wei, Junmin, et al.
Publicado: (2021)

A validated nomogram integrating hematological indicators to predict response to neoadjuvant therapy in esophageal squamous cell carcinoma patients
por: Wang, Sichao, et al.
Publicado: (2021)

Novel Immune Checkpoints in Esophageal Cancer: From Biomarkers to Therapeutic Targets
por: Zhou, Xueyin, et al.
Publicado: (2022)

Immune checkpoint inhibitors in esophageal squamous cell carcinoma: progress and opportunities
por: Jiao, Ruidi, et al.
Publicado: (2019)

Novel mutations in COL4A3, COL4A4, and COL4A5 in Chinese patients with Alport Syndrome
por: Liu, Jian-Hong, et al.
Publicado: (2017)

Possible biomarkers for predicting lymph node metastasis of esophageal squamous cell carcinoma: a review
por: Li, Juan, et al.
Publicado: (2019)

Serum Metabolomic Profiling Reveals Biomarkers for Early Detection and Prognosis of Esophageal Squamous Cell Carcinoma
por: Wang, Pan Pan, et al.
Publicado: (2022)

Untargeted Metabolomics Analysis of Esophageal Squamous Cell Carcinoma Discovers Dysregulated Metabolic Pathways and Potential Diagnostic Biomarkers
por: Zhu, Zi-Jia, et al.
Publicado: (2020)

Differential Expression of COL1A1, COL1A2, COL6A3, and SULF1 as Prognostic Biomarkers in Gastric Cancer
por: Hu, Yan, et al.
Publicado: (2021)

Immune checkpoint inhibitors for esophageal squamous cell carcinoma: a narrative review
por: Zhang, Wencheng, et al.
Publicado: (2020)

Tumor immune microenvironment and immune checkpoint inhibitors in esophageal squamous cell carcinoma
por: Baba, Yoshifumi, et al.
Publicado: (2020)

Global time trends in the incidence of esophageal squamous cell carcinoma
por: Wang, Qiao-Li, et al.
Publicado: (2018)

Combination of checkpoint inhibitors with radiotherapy in esophageal squamous cell carcinoma treatment: A novel strategy
por: Liao, Xiu-Yong, et al.
Publicado: (2019)

COL3A1 and MMP9 Serve as Potential Diagnostic Biomarkers of Osteoarthritis and Are Associated With Immune Cell Infiltration
por: Li, Shushan, et al.
Publicado: (2021)

Successful immune checkpoint inhibitor‐based rechallenge in a patient with advanced esophageal squamous cell cancer: A case report
por: Yao, Yanhong, et al.
Publicado: (2022)

Evaluation of Serum Exosomal lncRNAs as Diagnostic and Prognostic Biomarkers for Esophageal Squamous Cell Carcinoma
por: Yan, Suzhen, et al.
Publicado: (2020)

Oncogenic enhancers drive esophageal squamous cell carcinogenesis and metastasis
por: Ye, Bo, et al.
Publicado: (2021)

COL11A1 as a potential prognostic target for oral squamous cell carcinoma
por: Di, Yong-Bin, et al.
Publicado: (2022)

Predictive value of the presence of Prevotella and the ratio of Porphyromonas gingivalis to Prevotella in saliva for esophageal squamous cell carcinoma
por: Chen, Xiaohui, et al.
Publicado: (2022)

Postoperative Adjuvant Therapy for Patients with pN+ Esophageal Squamous Cell Carcinoma
por: Li, Juan, et al.
Publicado: (2021)

Construction of the Six-lncRNA Prognosis Signature as a Novel Biomarker in Esophageal Squamous Cell Carcinoma
por: Zheng, Ze-Jun, et al.
Publicado: (2022)

Changes in the expression of MMP2, MMP9, and ColIV in stromal cells in oral squamous tongue cell carcinoma: relationships and prognostic implications
por: Fan, Hai-Xia, et al.
Publicado: (2012)

Biomarkers of apoptosis and survival in esophageal squamous cell carcinoma
por: Takikita, Mikiko, et al.
Publicado: (2009)

Clinical characteristics and the identification of novel mutations of COL1A1 and COL1A2 in 61 Chinese patients with osteogenesis imperfecta
por: Zhang, Hao, et al.
Publicado: (2017)

Clinical significance of COL1A1 and COL1A2 expression levels in hypopharyngeal squamous cell carcinoma
por: Lin, Peiliang, et al.
Publicado: (2020)

Autoantibodies as Potential Biomarkers for the Early Detection of Esophageal Squamous Cell Carcinoma
por: Xu, Yi-Wei, et al.
Publicado: (2014)

Correlation of CD146 expression and clinicopathological characteristics in esophageal squamous cell carcinoma
por: LI, YAN, et al.
Publicado: (2014)

COL11A1 promotes esophageal squamous cell carcinoma proliferation and metastasis and is inversely regulated by miR-335-5p
por: Kang, Zheng, et al.
Publicado: (2021)

Phosphorylated AKT1 is associated with poor prognosis in esophageal squamous cell carcinoma
por: Zhu, Zhengfei, et al.
Publicado: (2015)

The staging performance of a modified tumor-node-metastasis staging system incorporated with lymphovascular invasion in patients with esophageal squamous cell carcinoma
por: Zhuang, Weitao, et al.
Publicado: (2022)

Five-lncRNA signature in plasma exosomes serves as diagnostic biomarker for esophageal squamous cell carcinoma
por: Jiao, Zichen, et al.
Publicado: (2020)

Role of COL3A1 and POSTN on Pathologic Stages of Esophageal Cancer
por: Zhang, Shao-wei, et al.
Publicado: (2020)

Anti-CXCL8 Autoantibody: A Potential Diagnostic Biomarker for Esophageal Squamous Cell Carcinoma
por: Chen, Huili, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_k46jk0bn0p8a60ej91ggnb407q